Morphose

The computed 12-month bankruptcy probability of Morphose is 3.7% (moderate). The 2025 annual accounts show negative equity (-€55,345) and a net result of €422. Equity remains stable across the filed fiscal years (±1.6% per year). Its solvency ranks better than 6% of 21069 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.